Medikaloka Hermina PT (HEAL) — Cash Flow Reinvestment Rate
Medikaloka Hermina PT (HEAL) has a Cash Flow Reinvestment Rate of 3.96x as of June 2025, reinvesting Rp893.33 Billion (capex Rp442.71 Billion plus investments Rp-450.61 Billion) from operating cash flow of Rp225.37 Billion. Explore capital reinvestment ratio of Medikaloka Hermina PT to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Medikaloka Hermina PT Cash Flow Reinvestment Rate (2015–2024)
Historical reinvestment intensity for Medikaloka Hermina PT across 10 annual periods. Also explore Medikaloka Hermina PT total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Medikaloka Hermina PT (2015–2024)
Year-by-year capital reinvestment analysis for Medikaloka Hermina PT. For live market cap and broader valuation context, see HEAL company net worth.
| Year | Reinvestment Rate | Total Reinvested (IDR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.08x | Rp4.65 Trillion | Rp1.14 Trillion | Rp2.28 Trillion | ▲ +64.8% |
| 2023 | 2.48x | Rp3.27 Trillion | Rp1.32 Trillion | Rp1.59 Trillion | ▲ +10.5% |
| 2022 | 2.24x | Rp1.13 Trillion | Rp503.58 Billion | Rp1.13 Trillion | ▲ +211.9% |
| 2021 | 0.72x | Rp1.33 Trillion | Rp1.86 Trillion | Rp1.21 Trillion | ▼ -19.9% |
| 2020 | 0.90x | Rp1.01 Trillion | Rp1.13 Trillion | Rp889.65 Billion | ▼ -26.3% |
| 2019 | 1.22x | Rp697.10 Billion | Rp572.58 Billion | Rp575.94 Billion | ▼ -66.8% |
| 2018 | 3.66x | Rp885.32 Billion | Rp241.67 Billion | Rp764.16 Billion | ▲ +18.0% |
| 2017 | 3.10x | Rp1.44 Trillion | Rp465.08 Billion | Rp696.31 Billion | ▲ +117.4% |
| 2016 | 1.43x | Rp517.92 Billion | Rp362.85 Billion | Rp487.92 Billion | ▼ -24.4% |
| 2015 | 1.89x | Rp482.66 Billion | Rp255.71 Billion | Rp452.66 Billion | — |